Previous Article | Next Article ![]()
Journal of Virology, December 2001, p. 11700-11708, Vol. 75, No. 23
Institut für Immunologie,
Bundesforschungsanstalt für Viruskrankheiten der Tiere,
Tübingen,1 and Institut
für Neuropathologie, Heinrich-Heine-Universität,
Düsseldorf,2 Germany
Received 7 May 2001/Accepted 9 August 2001
Experimental Borna disease virus (BDV) infection of rats and
natural infection of horses and sheep leads to severe central nervous
system disease based on immunopathological pathways. The virus
replicates slowly, and the cellular immune response results in
immunopathology. CD8+ T cells exert effector cell
functions, and their activity results in the destruction of
virus-infected cells. Previously, Oldach and colleagues (D. Oldach, M. C. Zink, J. M. Pyper, S. Herzog, R. Rott, O. Narayan, and J. E. Clements, Virology 206:426-434, 1995) have reported protection against
Borna disease after inoculation of high-dose cell-adapted BDV. Here we
show that the outcome of the infection, i.e., immunopathology versus
protection, is simply dependent on the amount of virus used for
infection. High-dose BDV (106 FFU) triggers an early
virus-specific reaction of the immune system, as demonstrated by strong
cellular and humoral responses. In particular, the early presence and
function of nucleoprotein-specific CD8+ T cells could be
demonstrated in the brain. We present evidence that in a noncytolytic
and usually persistent virus infection, high-dose input virus mediates
early control of the pathogen due to an efficient induction of an
antiviral immune mechanism. From these data, we conclude that immune
reactivity, in particular the cytotoxic T-cell response, determines
whether the virus is controlled with prevention of the ensuing
immunopathological disease or whether a persistent infection is established.
0022-538X/01/$04.00+0 DOI: 10.1128/JVI.75.23.11700-11708.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
High-Dose Borna Disease Virus Infection Induces a
Nucleoprotein-Specific Cytotoxic T-Lymphocyte Response and
Prevention of Immunopathology

*
Corresponding author. Mailing address: Institut
für Immunologie, Bundesforschungsanstalt für
Viruskrankheiten der Tiere, Paul Ehrlich Str. 28, 72076 Tübingen,
Germany. Phone: 49 7071 967 254. Fax: 49 7071 967 105. E-mail:
oliver.planz{at}tue.bfav.de.
Dedicated to Rudolf Rott on the occasion of his 75th birthday.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»